Gotham Asset Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,375,482
+31.8%
26,518
+25.3%
0.05%
+25.6%
Q2 2023$1,802,073
+190.4%
21,166
+182.3%
0.04%
+160.0%
Q1 2023$620,460
-32.5%
7,498
-35.8%
0.02%
-42.3%
Q4 2022$919,025
+141.2%
11,685
+127.2%
0.03%
+136.4%
Q3 2022$381,000
+13.7%
5,143
-0.0%
0.01%0.0%
Q2 2022$335,000
-2.0%
5,144
-20.3%
0.01%0.0%
Q4 2021$342,000
-28.8%
6,453
-5.0%
0.01%
-42.1%
Q3 2021$480,000
-19.9%
6,794
+1.6%
0.02%
+5.6%
Q2 2020$599,000
-71.7%
6,684
-68.6%
0.02%
-69.5%
Q1 2020$2,119,000
+277.0%
21,266
+335.0%
0.06%
+490.0%
Q4 2019$562,000
-65.6%
4,889
-73.8%
0.01%
-58.3%
Q1 2019$1,632,000
-55.6%
18,653
-49.3%
0.02%
-57.9%
Q4 2018$3,678,000
-29.7%
36,764
-19.5%
0.06%
-20.8%
Q3 2018$5,233,000
+5.2%
45,667
-17.7%
0.07%0.0%
Q2 2018$4,975,000
-55.9%
55,472
-64.1%
0.07%
-54.4%
Q1 2018$11,292,000
+674.0%
154,341
+514.3%
0.16%
+652.4%
Q4 2017$1,459,000
-41.5%
25,123
-54.8%
0.02%
-43.2%
Q3 2017$2,493,000
+68.4%
55,561
+48.3%
0.04%
+76.2%
Q2 2017$1,480,000
+130.9%
37,473
+137.1%
0.02%
+162.5%
Q1 2017$641,000
-44.1%
15,808
-60.1%
0.01%
-42.9%
Q2 2016$1,147,000
-21.4%
39,575
+12.2%
0.01%
+16.7%
Q2 2015$1,459,000
+332.9%
35,271
+369.7%
0.01%
+300.0%
Q1 2015$337,000
-67.3%
7,510
-74.6%
0.00%
-70.0%
Q3 2014$1,031,000
-24.2%
29,531
-23.5%
0.01%
-41.2%
Q2 2014$1,361,000
-2.4%
38,590
-9.9%
0.02%
-19.0%
Q1 2014$1,395,00042,8090.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders